Belmore Neidrauer was recognized for acting on behalf of Janssen in the LMG Life Sciences Patent Impact Case of the Year Teva v Janssen (2023 FCA 68) at the 2023 LMG Life Sciences Americas Awards.
Belmore Neidrauer is pleased to announce that the firm has been shortlisted for Firm of the Year – Patent Disputes (Canada) at the upcoming Managing IP Awards 2025.
It is with heartfelt sadness we share the passing of Belmore Neidrauer’s senior Partner and our dear friend Peter Wilcox.
Peter was a fierce advocate for his clients, a deeply respected leader and force in the IP community, and an incredible mentor to our team and to many others in the profession.
